India Today on MSN
Child vaccination to obesity rates, top 10 findings from NFHS-6
While several maternal and child health indicators showed significant improvement in the latest National Family Health Survey ...
Doctors say obesity is complex, and advanced treatments like ESG and gastric balloons may help when traditional diets fail.
Ozempic and its ilk are inescapable. While those on the weight loss drug often face more judgment and stigma, it’s undeniable ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that new data from its obesity portfolio will be presented at the 2026 Scientific Sessions of the American Diabetes ...
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
Health experts warn that rising levels of obesity among women can significantly increase risk of several non-communicable ...
The popular new drug can bring dramatic weight loss for some patients. But for NZ, tackling a rising obesity epidemic is ...
4don MSN
Novo Nordisk Is Beating Eli Lilly in the Obesity Pill Market. Should Lilly Investors Be Worried?
There is no reason to panic just yet.
New data seems to show that GLP-1 medications like semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, ...
The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will restore coverage to obesity products from Eli Lilly, ...
The National Family Health Survey-6 reveals a troubling increase in obesity and high blood sugar levels among Indian adults, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results